NEW YORK, Sept. 4 - French pharmaceutical company Sanofi-Synthelabo has become the latest subscriber to LifeSpan BioSciences' G protein-coupled receptor expression and location database, LifeSpan announced on Tuesday.

Sanofi will use LifeSpan’s database of GPCR expression and location information in normal and diseased tissues to help it identify and validate new drug targets.

Financial details of the agreement were not disclosed. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.